Public concerns for patient safety prompt changes in clinical trial policies

被引：0
|
作者：
Wechsler, J
机构：
来源：
FORMULARY | 2000年 / 35卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：853 / +
页数：2
相关论文
共 50 条
  • [21] Changes in Patient Safety Culture in Palestinian Public Hospitals: Impact of Quality and Patient Safety Initiatives and Programs
    Hamdan, Motasem
    Saleem, Abed Alra'oof
    JOURNAL OF PATIENT SAFETY, 2018, 14 (03) : E67 - E73
  • [22] Effectiveness of a Question Prompt List on Patient-Reported Concerns and Well-Being: A Multisite Randomized Controlled Trial
    Kata, Anna
    Buffington, Anne
    Tucholka, Jennifer L.
    Brasel, Karen J.
    Cooper, Zara
    Finlayson, Emily
    Mosenthal, Anne C.
    Hanlon, Bret M.
    Marka, Nicholas A.
    Schwarze, Margaret L.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S85 - S85
  • [23] Development of a patient question prompt list to improve communication and clinical trial enrollment in a diverse patient population.
    Hamel, Lauren M.
    Penner, Louis
    Heath, Elisabeth I.
    Lansey, Dina
    Carducci, Michael Anthony
    Albrecht, Terrance Lynn
    Barton, Ellen
    Manning, Mark A.
    Wojda, Mark
    Eggly, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [24] Immigration, Sanctuary Policies, and Public Safety
    Amuedo-Dorantes, Catalina
    Puttitanun, Thitima
    Lopez, Mary
    INTERNATIONAL MIGRATION REVIEW, 2022, 56 (03) : 668 - 701
  • [25] A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns
    Kolstoe, Simon E.
    Davies, Hugh
    Messer, Janet
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 12 : 198 - 198
  • [26] Y2K concerns prompt another public disclosure battle
    Chemical Week, 1999, 161 (48):
  • [27] FRESH SAFETY CONCERNS STALL ANTICANCER TRIAL
    BROWN, P
    NEW SCIENTIST, 1992, 133 (1810) : 11 - 11
  • [28] Phase III Trial of EprotiromeDiscontinued for Safety Concerns
    Mel Sweetlove
    Pharmaceutical Medicine, 2012, 26 (3) : 185 - 187
  • [29] Malpractice and Patient Safety Concerns Their Influence on the Clinical Behaviors of Dermatopathologists Interpreting Melanocytic Lesions
    Reisch, Lisa M.
    Flores, Martiniano J.
    Radick, Andrea C.
    Shucard, Hannah L.
    Kerr, Kathleen F.
    Piepkorn, Michael W.
    Barnhill, Raymond L.
    Elder, David E.
    Knezevich, Stevan R.
    Elmore, Joann G.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (05) : 700 - 707
  • [30] Iseganan trial discontinued due to safety concerns
    Reactions Weekly, 2004, 1009 (1) : 3 - 3
12345